Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ZYDUS WORLDWIDE DMCC

  • FDA Approval
  • Oct. 14, 2022, 10:57 UTC
  • 30
  • 0 comments

FDA approve VALBENAZINE TOSYLATE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 14, 2022, 10:34 UTC
  • 33
  • 0 comments

FDA approve LITHIUM CITRATE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 14, 2022, 10:34 UTC
  • 32
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

HIKMA

  • FDA Approval
  • Oct. 14, 2022, 10:30 UTC
  • 31
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 29
  • 0 comments

FDA approve VIGABATRIN

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 26
  • 0 comments

FDA approve EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE

Comment Full text

MSD SUB MERCK

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 24
  • 0 comments

FDA approve ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Comment Full text

MSD SUB MERCK

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 26
  • 0 comments

FDA approve ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Comment Full text

MSD SUB MERCK

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 28
  • 0 comments

FDA approve ERTUGLIFLOZIN

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Oct. 14, 2022, 02:42 UTC
  • 26
  • 0 comments

FDA approve DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 961
  • 962
  • 963
  • 964
  • 965
  • Next

Search

News categories

  • Technical Exchange News(12339)
  • Event(6229)
  • SEC News(269573)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(156810)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin